Skip to content


Betagan (levobunolol) is a small molecule pharmaceutical. Levobunolol was first approved as Betagan on 1985-12-19. It is used to treat open-angle glaucoma in the USA. The pharmaceutical is active against beta-3 adrenergic receptor, beta-2 adrenergic receptor, and beta-1 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor.
Trade Name Betagan
Common Name Levobunolol
Indication open-angle glaucoma
Drug Class Beta-blockers (propranolol type)
Get full access now